rs9274407
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_002123.5(HLA-DQB1):c.122T>G(p.Phe41Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.0000077 ( 0 hom., cov: 20)
Exomes 𝑓: 8.2e-7 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
HLA-DQB1
NM_002123.5 missense
NM_002123.5 missense
Scores
2
16
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -7.44
Publications
72 publications found
Genes affected
HLA-DQB1 (HGNC:4944): (major histocompatibility complex, class II, DQ beta 1) HLA-DQB1 belongs to the HLA class II beta chain paralogs. This class II molecule is a heterodimer consisting of an alpha (DQA) and a beta chain (DQB), both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages). The beta chain is approximately 26-28 kDa and it contains six exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, exon 4 encodes the transmembrane domain and exon 5 encodes the cytoplasmic tail. Within the DQ molecule both the alpha chain and the beta chain contain the polymorphisms specifying the peptide binding specificities, resulting in up to four different molecules. Typing for these polymorphisms is routinely done for bone marrow transplantation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -2 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.11160529).
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000768 AC: 1AN: 130260Hom.: 0 Cov.: 20 show subpopulations
GnomAD3 genomes
AF:
AC:
1
AN:
130260
Hom.:
Cov.:
20
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00 AC: 0AN: 176342 AF XY: 0.00
GnomAD2 exomes
AF:
AC:
0
AN:
176342
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 8.18e-7 AC: 1AN: 1222162Hom.: 0 Cov.: 28 AF XY: 0.00000163 AC XY: 1AN XY: 612118 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
1
AN:
1222162
Hom.:
Cov.:
28
AF XY:
AC XY:
1
AN XY:
612118
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
0
AN:
27068
American (AMR)
AF:
AC:
0
AN:
39622
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
23026
East Asian (EAS)
AF:
AC:
0
AN:
36414
South Asian (SAS)
AF:
AC:
0
AN:
74884
European-Finnish (FIN)
AF:
AC:
0
AN:
49660
Middle Eastern (MID)
AF:
AC:
0
AN:
4524
European-Non Finnish (NFE)
AF:
AC:
1
AN:
916244
Other (OTH)
AF:
AC:
0
AN:
50720
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.275
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00000768 AC: 1AN: 130260Hom.: 0 Cov.: 20 AF XY: 0.0000158 AC XY: 1AN XY: 63264 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome
AF:
AC:
1
AN:
130260
Hom.:
Cov.:
20
AF XY:
AC XY:
1
AN XY:
63264
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
0
AN:
34006
American (AMR)
AF:
AC:
0
AN:
13492
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3180
East Asian (EAS)
AF:
AC:
0
AN:
4644
South Asian (SAS)
AF:
AC:
0
AN:
3692
European-Finnish (FIN)
AF:
AC:
0
AN:
9050
Middle Eastern (MID)
AF:
AC:
0
AN:
262
European-Non Finnish (NFE)
AF:
AC:
1
AN:
59396
Other (OTH)
AF:
AC:
0
AN:
1708
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.275
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Benign
DEOGEN2
Benign
T;T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T;.;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
PhyloP100
PrimateAI
Benign
T
PROVEAN
Benign
N;N;N;N
REVEL
Benign
Sift
Uncertain
D;D;D;D
Sift4G
Benign
T;T;T;T
Polyphen
P;.;B;B
Vest4
MutPred
Gain of ubiquitination at K44 (P = 0.0686);Gain of ubiquitination at K44 (P = 0.0686);Gain of ubiquitination at K44 (P = 0.0686);Gain of ubiquitination at K44 (P = 0.0686);
MVP
MPC
1.2
ClinPred
D
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.